TY - JOUR
T1 - Genomic, transcriptomic and metabolomic studies of two well-characterized, laboratory-derived vancomycin-intermediate Staphylococcus aureus strains derived from the same parent strain
AU - Hattangady, Dipti S.
AU - Singh, Atul K.
AU - Muthaiyan, Arun
AU - Jayaswal, Radheshyam K.
AU - Gustafson, John E.
AU - Ulanov, Alexander V.
AU - Li, Zhong
AU - Wilkinson, Brian J.
AU - Pfeltz, Richard F.
N1 - Publisher Copyright:
© 2015 by the authors; licensee MDPI, Basel, Switzerland.
PY - 2015/2/4
Y1 - 2015/2/4
N2 - Complete genome comparisons, transcriptomic and metabolomic studies were performed on two laboratory-selected, well-characterized vancomycin-intermediate Staphylococcus aureus (VISA) derived from the same parent MRSA that have changes in cell wall composition and decreased autolysis. A variety of mutations were found in the VISA, with more in strain 13136p-m+V20 (vancomycin MIC = 16 µg/mL) than strain 13136p-m+V5 (MIC = 8 µg/mL). Most of the mutations have not previously been associated with the VISA phenotype; some were associated with cell wall metabolism and many with stress responses, notably relating to DNA damage. The genomes and transcriptomes of the two VISA support the importance of gene expression regulation to the VISA phenotype. Similarities in overall transcriptomic and metabolomic data indicated that the VISA physiologic state includes elements of the stringent response, such as down regulation of protein and nucleotide synthesis, the pentose phosphate pathway and nutrient transport systems. Gene expression for secreted virulence determinants was generally down regulated, but was more variable for surface-associated virulence determinants, although capsule formation was clearly inhibited. The importance of activated stress response elements could be seen across all three analyses, as in the accumulation of osmoprotectant metabolites such as proline and glutamate. Concentrations of potential cell wall precursor amino acids and glucosamine were increased in the VISA strains. Polyamines were decreased in the VISA, which may facilitate the accrual of mutations. Overall, the studies confirm the wide variability in mutations and gene expression patterns that can lead to the VISA phenotype.
AB - Complete genome comparisons, transcriptomic and metabolomic studies were performed on two laboratory-selected, well-characterized vancomycin-intermediate Staphylococcus aureus (VISA) derived from the same parent MRSA that have changes in cell wall composition and decreased autolysis. A variety of mutations were found in the VISA, with more in strain 13136p-m+V20 (vancomycin MIC = 16 µg/mL) than strain 13136p-m+V5 (MIC = 8 µg/mL). Most of the mutations have not previously been associated with the VISA phenotype; some were associated with cell wall metabolism and many with stress responses, notably relating to DNA damage. The genomes and transcriptomes of the two VISA support the importance of gene expression regulation to the VISA phenotype. Similarities in overall transcriptomic and metabolomic data indicated that the VISA physiologic state includes elements of the stringent response, such as down regulation of protein and nucleotide synthesis, the pentose phosphate pathway and nutrient transport systems. Gene expression for secreted virulence determinants was generally down regulated, but was more variable for surface-associated virulence determinants, although capsule formation was clearly inhibited. The importance of activated stress response elements could be seen across all three analyses, as in the accumulation of osmoprotectant metabolites such as proline and glutamate. Concentrations of potential cell wall precursor amino acids and glucosamine were increased in the VISA strains. Polyamines were decreased in the VISA, which may facilitate the accrual of mutations. Overall, the studies confirm the wide variability in mutations and gene expression patterns that can lead to the VISA phenotype.
KW - Genomics
KW - Metabolomics
KW - Staphylococcus aureus
KW - Transcriptomics
KW - VISA
UR - http://www.scopus.com/inward/record.url?scp=84996978995&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84996978995&partnerID=8YFLogxK
U2 - 10.3390/antibiotics4010076
DO - 10.3390/antibiotics4010076
M3 - Article
C2 - 27025616
AN - SCOPUS:84996978995
SN - 2079-6382
VL - 4
SP - 76
EP - 112
JO - Antibiotics
JF - Antibiotics
IS - 1
ER -